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Summary
 
Interferon 
 
g
 
 (IFN-
 
g
 
) has been implicated in T helper type 1 (Th1) cell development through
its ability to optimize interleukin 12 (IL-12) production from macrophages and IL-12 receptor
expression on activated T cells. Various systems have suggested a role for IFN-
 
g
 
 derived from
the innate immune system, particularly natural killer (NK) cells, in mediating Th1 differentia-
tion in vivo. We tested this requirement by reconstituting T cell and IFN-
 
g
 
 doubly deficient
mice with wild-type CD4
 
1
 
 T cells and challenging the mice with pathogens that elicited either
minimal or robust IL-12 in vivo (
 
Leishmania major
 
 or 
 
Listeria monocytogenes
 
, respectively). Th1
cells developed under both conditions, and this was unaffected by the presence or absence of
IFN-
 
g
 
 in non-T cells. Reconstitution with IFN-
 
g
 
–deficient CD4
 
1
 
 T cells could not reestab-
lish control over 
 
L. major
 
, even in the presence of IFN-
 
g
 
 from the NK compartment. These
data demonstrate that activated T cells can maintain responsiveness to IL-12 through elabora-
tion of endogenous IFN-
 
g
 
 without requirement for an exogenous source of this cytokine.
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T
 
he development of CD4
 
1
 
 T cell subsets remains an
important topic in understanding mechanisms by
which protective or detrimental T effector cell populations
arise (1, 2). Critical cytokines that promote the appearance
of Th1 cells include IL-12 and IL-18, which provide im-
portant growth and survival signals for this subset of cells
(3–5). The canonical Th1 cytokine, IFN-
 
g
 
, may also con-
tribute to Th1 development, since mice deficient in IFN-
 
g
 
(IFN-
 
g
 
2/2
 
) aberrantly developed Th2 cells when con-
fronted with pathogens that normally engender Th1 re-
sponses (6–8).
IFN-
 
g
 
 can influence Th1 development by several mech-
anisms. IFN-
 
g
 
 mediates IL-12R
 
b
 
2 chain expression (9)
and promotes IL-12 secretion from macrophages (10).
Since both IL-12 and a functional IL-12 receptor are re-
quired for the development of fully competent Th1 cells
(3, 11, 12), the requirement for IFN-
 
g
 
 may be indirect.
Because naive T cells do not produce IFN-
 
g
 
 until some
time after activation, it is possible that IFN-
 
g
 
 derived upon
activation of NK cells (13) may prime Th1 development
through its ability to confer a competent IL-12 response to
the T cells. IFN-
 
g
 
 derived from Th1 cells can also nega-
tively regulate the growth of Th2 cells (14). Such studies
predict that T cells conditioned in vivo in the absence of a
source of exogenous IFN-
 
g
 
 might display defective Th1
development.
To examine the relative contributions of NK cell– and T
cell–derived IFN-
 
g
 
 in Th1 development, we have gener-
ated mice with a selective deficiency of IFN-
 
g
 
 in either the
NK cell or T cell compartments. The mice were chal-
lenged with pathogens that in the early stages of infection
elicit either little (e.g., 
 
Leishmania major
 
; reference 15) or
robust (e.g., 
 
Listeria monocytogenes
 
; reference 16) amounts of
IL-12 in vivo, and were assayed for their capacity to de-
velop Th1 cells.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice, and IFN-
 
g
 
2/2
 
 (17) and recombinase
activating gene 1–deficient (RAG1
 
2/2
 
; reference 18) mice (all 6–8
wk old) on the C57BL/6 background were purchased from The
Jackson Laboratory (Bar Harbor, ME). Mice were bred in the
UCSF transgenic facility to generate doubly deficient mice (IFN-
 
g
 
2/2
 
RAG1
 
2/2
 
). The RAG1
 
2/2
 
 phenotype was confirmed by
flow cytometric demonstration of complete blood T and B cell
deficiency and the IFN-
 
g
 
2/2
 
 genotype was confirmed by PCR
amplification of the targeted alleles from genomic DNA for the
 
1
 
Abbreviation used in this paper:
 
 RAG-1
 
2/2
 
, recombinase activating gene–
deficient mice.
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presence of the introduced construct and the absence of the wild-
type gene as described (17).
 
CD4
 
1
 
 T Cell Purification and Adoptive Transfer.
 
Lymph nodes
and spleens were collected from designated mice and dispersed
through a 0.75-
 
m
 
m nylon mesh filter to produce single cell sus-
pensions. After washing and counting, suspensions were depleted
of B, dendritic, and CD8
 
1
 
 T cells by treatment with mAbs
against heat-stable antigen (J11d; American Type Culture Collec-
tion [ATCC], Rockville, MD), MHC class II (BP107; ATCC),
and CD8 (3.155; ATCC), followed by treatment with rabbit and
guinea pig complement (Cedarlane Labs., Hornby, Ontario,
Canada). After removal of dead cells over a Ficoll gradient, cells
(routinely 75–85% CD4
 
1
 
 T cells) were labeled with FITC-con-
jugated anti-Thy 1.2 (5a-8; Caltag Labs., S. San Francisco, CA),
PE-conjugated anti-NK1.1 (PK136; PharMingen, San Diego,
CA), and TriColor-conjugated anti-CD4 mAbs (CT-CD4; Cal-
tag Labs.), and then sorted using flow cytometry (FACStar
PLUS
 
Ò
 
, Becton Dickinson, Mountain View, CA) to collect
CD4
 
1
 
Thy1.2
 
1
 
NK1.1
 
2
 
 cells (
 
.
 
99% purity). Designated cohorts
of recipient mice were reconstituted intraperitoneally with 10
 
6
 
cells in 400 
 
m
 
l PBS with 1% FCS.
 
Leishmania Infection. L. major
 
 (strain WHOM/IR/-/173)
was grown in M199 medium supplemented with 30% FCS and
antibiotics. For infection, metacyclic promastigotes were purified
from stationary phase cultures by negative selection with peanut
lectin–coated beads (Sigma Chemical Co., St. Louis, MO) as pre-
viously described (15). Designated groups of four to eight mice
were inoculated with 4 
 
3 
 
10
 
5
 
 organisms in each hind footpad.
Footpad swelling was quantitated weekly using a metric caliper.
At various times, mice were killed and the footpads and spleens
were collected for quantitation of parasites as previously described
(11). In brief, single cell suspensions were prepared and diluted
serially 10-fold in triplicate microtiter wells in M199 medium
with 30% FCS and antibiotics. After incubation for 2 wk at 26
 
8
 
C,
motile promastigotes were identified using inverted microscopy.
 
Listeria Infection. L. monocytogenes
 
 (provided by D. Portnoy,
U.C. Berkeley, Berkeley, CA) was maintained as frozen stock
and grown in Luria-Bertani medium. Mice were infected intra-
peritoneally with 10
 
4
 
 organisms in 100 
 
m
 
l of PBS. Mice were
killed after 8 d and the spleens were collected for analysis of cy-
tokines (see below).
 
ELISPOT Assays for Cytokine Production.
 
Spleens from mice
infected with 
 
L. major
 
 or 
 
Listeria
 
 were dispersed into single cell
suspensions in RPMI with 10% FCS and antibiotics (culture me-
dium). Production of IL-4 and IFN-
 
g
 
 by individual cells was de-
termined using an ELISPOT assay as previously described (7). In
brief, duplicate aliquots (containing between 2.5 
 
3 
 
10
 
5
 
 and 1 
 
3
 
10
 
6
 
 cells in various experimental groups) were diluted twofold
across 96-well microtiter plates (Immulon II; Dynatech, Chan-
tilly, VA) that had been precoated with either mAb 11B11 against
IL-4 or mAb R46A2 against IFN-
 
g
 
. Plates were incubated over-
night at 37
 
8
 
C in 5% CO
 
2
 
-air. The wells were washed and incu-
bated for 1 h with biotinylated secondary antibodies BVD6-
24G2.3 and XMG-6 for IL-4 and IFN-
 
g
 
, respectively. Wells
were washed and incubated with streptavidin alkaline phos-
phatase (Jackson ImmunoResearch Labs., West Grove, PA) and
developed colorimetrically with 5-bromo-4-chloro-3-indolyl-
phosphate in 0.1 M 2-amino-2-methyl-1-propanol buffer (Sigma
Chemical Co.) suspended in 0.6% agarose (SeaPlaque; FMC Bio-
products, Rockland, ME). After solidification, blue spots were
counted by inverted microscopy.
 
Flow Cytometric Analysis and Intracellular Cytokine Detection.
 
Spleen cells collected from designated mice were analyzed for the
numbers of CD4
 
1
 
TCR
 
1
 
NK1.1
 
2
 
 and NK1.1
 
1
 
TCR
 
2
 
 cells using
FITC-conjugated anti-CD4 (Caltag Labs.), PE-conjugated anti-
NK1.1 (PharMingen), and TriColor-conjugated anti–TCR-
 
b
 
(Caltag Labs.) mAbs, using a Becton Dickinson Vantage flow cy-
tometer with Lysis II software (Becton Dickinson).
Intracellular cytokine detection was performed as previously
described (19). In brief, 3 
 
3 
 
10
 
6
 
 cells in 1 ml culture medium
were incubated in duplicate in 24-well plates that had been pre-
coated with anti–TCR-
 
b
 
 mAb (H57.597; 10 
 
m
 
g/ml) and anti-
CD28 mAb (37N51.1; 5 
 
m
 
g/ml). After 16 h at 37
 
8
 
C in 5% CO
 
2
 
,
cells were washed twice in PBS/1% FCS, incubated for 30 min
with FITC-conjugated anti-CD4 mAb, washed twice, and then
fixed with 4% formaldehyde for 10 min at room temperature. Af-
ter washing twice in PBS/1% FCS, cells were resuspended in
0.5% saponin (Sigma Chemical Co.) in PBS for 5–10 min. After
further washing, cells were incubated for 30 min with PE-conju-
gated 11B11 or PE-conjugated XMG1.2 (mAbs for IL-4 and
IFN-
 
g
 
, respectively), or PE-conjugated isotype control mAbs.
Cells were washed twice in 0.5% saponin/PBS and resuspended
in 200–500 
 
m
 
l of PBS/1% FCS for flow cytometric analysis.
 
Serum IgE Analysis.
 
Serum prepared at the time of death was
quantitated for total IgE using a mAb-based sandwich ELISA as
previously described (7).
 
NK Cytolytic Assay.
 
YAC-1 tumor targets (10
 
6
 
 cells) were la-
beled at 37
 
8
 
C for 1 h with 200 
 
m
 
Ci 
 
51
 
Cr-sodium chromate (Am-
ersham Pharmacia Biotech, Arlington Heights, IL) in RPMI
1640 supplemented with 10% FCS, antibiotics, 5 
 
3 
 
10
 
2
 
5
 
 M ME
(complete RPMI). Cells were washed twice in complete RPMI
and resuspended at 10
 
5
 
 cells/ml, and 10
 
4
 
 cells were added to trip-
licate microtiter wells of a 96-well plate. Serially diluted spleen
effector cells were added to each well at the indicated E/T ratios.
After 4 h at 37
 
8
 
C, the plates were centrifuged (200 g for 5 min)
and 100 ml supernatant from each well was counted in a gamma
counter. Percentage of cytotoxicity was calculated as previously
described (20). For each assay, the SE of each point was ,5%.
Results
NK Cell-derived IFN-g Is Not Required for Control of L.
major Infection. Prior studies of murine L. major infection,
including in C57BL/6 mice, have suggested a role for
IFN-g derived from NK cells in establishing Th1 cytokine
responses necessary for control of disease (21, 22). To assess
this directly, T cell–deficient mice were created on the
IFN-g2/2 background by crossing and selecting C57BL/6
mice doubly deficient for RAG-1 and IFN-g. As expected,
these mice, and singly deficient RAG-12/2 mice, expressed
no B or T lymphocytes. Analysis of spleens from such mice
revealed that the NK compartment, as assessed by NK1.11
TCR-a/b, -g/d2 cells, comprised z2.6 6 0.4 3 106 cells
in Rag-12/2 mice and 2.8 6 0.7 3 106 cells in RAG-12/2
IFN-g2/2 mice, as compared with 2.5 6 0.3 3 106 splenic
NK cells in wild-type C57BL/6 mice. Thus, despite the
substantial decrease in spleen size in RAG-12/2 and RAG-
12/2IFN-g2/2 mice, the numbers of NK cells were compa-
rable to wild-type mice.
The capacity of CD41 T cells to reconstitute host re-
sponses to L. major in immunodeficient mice (23) prompted
us to reconstitute such doubly deficient mice with 106
highly purified CD41 T cells from wild-type C57BL/6 an-
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imals. These adoptive transfers thus establish mice in which
the IFN-g–competent T cell compartment is donor de-
rived and the IFN-g2/2 NK cell compartment is recipient
derived. Mice were infected 2 d after reconstitution. In
three independent experiments, all reconstituted mice were
capable of controlling infection with L. major, as assessed by
lesion size over time and by the numbers of parasites recov-
ered from the footpads and spleens after 8 wk (Fig. 1 A). In
contrast, nonreconstituted mice were highly susceptible to
L. major infection (log10 parasites in footpads $1012 in both
and in spleens, 107.1 and 106.6 in RAG-12/2 and doubly de-
ficient mice, respectively), as expected based on prior stud-
ies in T cell–deficient and IFN-g2/2 mice (7, 11, 23).
Analysis of the reconstituted mice at the conclusion of the
experiment confirmed the purity of the CD41 T cell re-
constitution; CD81 T cells (,1%), g/d T cells (,1%), and
serum IgE (,1.2 mg/ml) were at or below the levels of de-
tection in nonreconstituted RAG-12/2 mice. The cytolytic
capacity of NK cells taken from the infected T cell–recon-
stituted IFN-g1/1 or 2/2 mice was comparable, as assessed
by the ability to kill labeled YAC-1 targets in vitro (Fig. 2).
Thus, wild-type CD41 T cells conferred a phenotypically
normal healer response to L. major in mice containing an
NK compartment unable to contribute the cytokine IFN-g.
L. major Infection Is Unaffected by the Presence of NK Cell–
derived IFN-g in the Absence of T Cell–derived IFN-g. To
assess whether IFN-g contributed from NK cells could im-
part any control over L. major, we reconstituted either
RAG-12/2 or doubly deficient mice with highly purified
CD41 T cells from IFN-g2/2 mice. Reconstituted RAG-
12/2 mice have intact IFN-g production from the NK cell
compartment, unlike the doubly deficient mice, which al-
lows us to compare the course of infection in the two co-
horts of animals. In two separate experiments, both recon-
stituted groups of mice were unable to control L. major,
and no significant differences were apparent among the
groups in either lesion size or parasite burdens (Fig. 1 B).
Indeed, susceptible BALB/c mice controlled infection bet-
ter than either cohort of reconstituted mice. Thus, IFN-g
derived from the NK cell compartment alone could not
sustain control of L. major in the absence of CD41 T cell–
derived IFN-g.
Th1 Cell Development Occurs in the Absence of NK Cell
IFN-g. Control of L. major among healer mice, including
C57BL/6 mice, is dependent upon the development of Th1
cells that produce IFN-g. As assessed by both ELISPOT
assays (data not shown) and intracellular cytokine determi-
nations (Fig. 3 A) in individual CD41 T cells, Th1, but not
Th2, cells developed effectively in doubly deficient mice
reconstituted with wild-type CD41 T cells. In contrast,
mice reconstituted with IFN-g2/2 CD41 T cells developed
IL-4–producing cells, and such cells developed in both
RAG-12/2 mice (990 6 95 IL-4–producing cells per 106
Figure 1. L. major infection in CD41 T cell–reconstituted mice. (A)
Groups of five to eight C57BL/6 RAG-12/2 or C57BL/6 RAG-12/2
IFN-g2/2 mice were reconstituted with 106 wild-type C57BL/6 CD41 T
cells 2 d before infection in the hind footpads with L. major. Cohorts of
wild-type resistant C57BL/6 and susceptible BALB/c mice were infected
concurrently. The course of infection was monitored by measurements of
local footpad swelling using a metric caliper. Bars represent SEM. Box to
right indicates log recovered parasites from footpads and spleens at the
conclusion of the experiment. (B) Same experimental groups as depicted
in A except that C57BL/6 RAG-12/2 and C57BL/6 RAG-12/2IFN-g2/2
mice were reconstituted with 106 CD41 T cells from C57BL/6 IFN-g2/2
mice 2 d before infection with L. major. Bars represent SEM. Box to right
indicates tissue parasite burdens.
Figure 2. NK lytic activity from reconstituted mice. Spleen cells were
recovered at the conclusion of L. major infection from two individual
RAG-12/2 or RAG-12/2IFN-g2/2 mice that had been reconstituted
with wild-type CD41 T cells. Cells were diluted at the designated E/T
ratios into cultures with labeled YAC-1 target cells. Percentage of lysis
was calculated by the proportion of label released into the supernatant as a
percentage of the total label released by nonspecific lysis of the cells with
detergent.
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spleen cells) or doubly deficient mice (2,050 6 960 IL-4–
producing cells per 106 spleen cells) in numbers comparable
to infected susceptible BALB/c mice (1,250 6 170/106
spleen cells) and greater than those in resistant C57BL/6
mice (225 6 10/106 spleen cells). Thus, under these condi-
tions, Th1 cell development was unimpeded and Th2 de-
velopment was not apparent in mice containing IFN-g2/2
NK cells. Conversely, development of IL-4–producing
cells occurred when IFN-g2/2 CD41 T cells were used in
the reconstitutions despite the absence or presence of IFN-g
in non-T cells.
L. major is a relatively subacute infection that develops
over weeks. It is possible that some kinetic deficit in Th1
development was missed in the doubly deficient mice due
to the relatively slow course of infection. To address this is-
sue, we compared the development of Th1 cells in doubly
deficient mice reconstituted with wild-type CD41 T cells
and then inoculated with L. monocytogenes, a gram-positive
bacterium that is capable of inducing strong Th1 responses
(16). As assessed by both ELISPOT (data not shown) and
intracellular cytokine determinations (Fig. 3 B), Th1 cells
also developed in these mice, indicating that the results
seen with L. major were not limited to that organism.
Discussion
These studies demonstrate that Th1 cells can differentiate
in vivo without exposure to IFN-g from other cells, such
as NK cells. Differentiated cells were functionally compe-
tent, as assessed by their capacity to maintain control over a
parasite, L. major, which is crucially dependent upon Th1
development (24). Finally, we were unable, at least under
these conditions, to define a role for IFN-g derived from
NK cells in modulating, either positively or negatively,
Th1 effector differentiation. These data suggest that IFN-g
derived from CD41 T cells can autonomously modulate
responsiveness to IL-12 and Th1 competence.
The role of IFN-g in priming Th1 cell development has
been demonstrated using transgenic T cells in vitro (25–
28), and presumably reflects the capacity of IFN-g to pro-
mote IL-12Rb2 chain expression and the appearance of
competent IL-12 receptors on activated CD41 lympho-
cytes (9, 29). IFN-g also induces IL-12 p40 production by
macrophages (10), thus establishing an autocrine loop for
the amplification of type 1 immunity. The importance of
this pathway was revealed by the profound Th1 deficiency
in mice with genetic deletion of members of the IL-12 sig-
naling cascade, including IL-12, IL-12Rb1, and stat4 (3,
12, 30, 31). Interestingly, IFN-g has also been implicated
in Th1 development in vivo in some systems (6–8, 32),
consistent with effects mediated indirectly through IL-12.
The exquisite sensitivity of BALB/c mice to L. major infec-
tion has been proposed to develop due to premature
downregulation of competent IL-12 receptors on activated
CD41 T cells (33, 34). Such a defect might be secondary to
the decreased IFN-g produced after activation of BALB/c
CD41 T cells as compared with cells from other inbred
mouse strains (35).
The earliest expression of IFN-g after infection with L.
major was shown to arise not in CD41 T cells, but in the
NK cell population (15, 21, 22, 36). Despite these observa-
tions, the studies here suggest that IFN-g derived from the
NK cell population was neither required for Th1 cell dif-
ferentiation nor for the control of L. major. Conversely, we
could discern no control of infection through IFN-g de-
rived from the NK cell population in the absence of CD41
T cell–derived IFN-g, although this may reflect the smaller
contribution made by NK cells in C57BL/6 mice (21).
The functional consequences of NK cell-depletion or acti-
vation that have been described in murine experimental
leishmaniasis may reflect contributions from NK cells that
are independent of IFN-g (21, 22). These findings contrast
with those in some viral systems, in which a critical role of
NK cell-derived IFN-g has been demonstrated (37), and
may reflect differences among CD41 and CD81 effector
cells. Further studies will be required to elucidate how ap-
plicable such studies are to other classes of pathogens. We
could discern no impact on Th1 development in the ab-
Figure 3. Intracellular cytokine
production by CD41 T cells. (A)
CD41 T cells from draining
lymph nodes were examined for
intracellular IFN-g or IL-4 using
flow cytometry (see Materials and
Methods) after 8 wk of infection
with L. major. Representative
panels from resistant C57BL/6,
susceptible BALB/c, and wild-
type CD41 T cell–reconstituted
RAG-12/2 IFN-g2/2 and RAG-
12/2 mice are shown. Results
were comparable in exams of four
to six mice under each set of con-
ditions in two separate experi-
ments. CD41 T cells from unin-
fected, age-matched, C57BL/6 mice revealed ,0.7% IFN-g–producing cells and ,0.2% IL-4–producing cells under the same experimental conditions.
(B) Intracellular cytokine staining after infection with Listeria. Spleen CD41 T cells were collected 8 d after infection from wild-type C57BL/6 or RAG2/2
IFN-g2/2 C57BL/6 mice that had been reconstituted with wild-type CD41 T cells 2 d before infection and examined for intracellular presence of IFN-g
and IL-4. Comparable results were obtained on three to four mice under each set of conditions in two separate experiments.
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sence of NK cell IFN-g after challenge with Listeria, a
more acute infectious disease than Leishmania. In L. major
infection, the earliest IFN-g and NK cell responses were
shown to be dependent on the induction of interferon a/b
by the parasite and the consequent induction of type 2 ni-
tric oxide synthase (38). As shown here in mice with intact
interferon a/b and type 2 nitric oxide synthase genes, these
early responses were unable to establish protective immu-
nity in the absence of IFN-g from CD41 T cells. This en-
dogenous source of IFN-g is presumably necessary and suf-
ficient to downregulate TGF-b activation that was felt to
contribute to early and rapid dissemination of the parasite
(38, 39). However, the consistently higher proportion of
Th1 cells that developed in the reconstituted doubly defi-
cient mice as compared with wild-type or reconstituted
RAG2/2 mice (Fig. 3, A and B) suggests that the total
amounts of IFN-g required for a given biologic response
may be regulated, suggesting that IFN-g derived from
non-T cells may have functional activity independent of ef-
fects on Th development.
These results suggest that IFN-g, in a cell-autonomous
manner, is required and sufficient to enable CD41 T cells
to respond to exogenous signals, such as IL-12 and IL-18,
to develop into functional Th1 effector cells. Similar con-
clusions have been reached regarding Th2 development, in
which autocrine IL-4 derived from T cells themselves was
sufficient to regulate this differentiative process (40–42). It
will be important to establish whether signals exogenous to
the T cells are required for Th2 development, akin to the
roles for IL-12 and IL-18 in Th1 development (3, 4). Such
insights will be critical in gaining understanding over the fi-
nal pathways that regulate these differentiative pathways in
vivo during allergic and inflammatory diseases, so that cell
autonomous and cell extrinsic regulatory molecules can be
efficiently targeted during immune intervention.
The authors thank E. Weider for assistance with cell sorting, A. O’Garra for assistance with the intracellular
cytokine staining protocol, and R. Coffman (DNAX Research Institute, Palo Alto, CA) for critical reagents.
This work was supported by National Institutes of Health grant AI26918, a grant from the Crohn’s and
Colitis Foundation, a Hefni Scholars Award to A.E. Wakil, and a Juvenile Diabetes Foundation International
Fellowship to D.J. Fowell. 
Address correspondence to R.M. Locksley, UCSF, Box 0654, C-443, 521 Parnassus Ave., San Francisco,
CA 94143. Phone: 415-476-9362; Fax: 415-476-9364; E-mail: rich_locksley@quickmail.ucsf.edu
Received for publication 10 July 1998 and in revised form 3 August 1998.
References
1. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional
diversity of helper T lymphocytes. Nature. 383:778–793.
2. O’Garra, A. 1998. Cytokines induce the development of
functionally heterogeneous T helper cell subsets. Immunity. 8:
275–283.
3. Magram, J., S.E. Connaughton, R.R. Warrer, D.M. Carva-
jal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A.
Faherty, and M.K. Gately. 1996. IL-12-deficient mice are
defective in IFN-g production. Immunity. 4:471–481.
4. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N.
Yoshida, T. Kishimoto, H. Okarmura, K. Nakanishi, and S.
Akira. 1998. Defective NK cell activity and Th1 response in
IL-18-deficient mice. Immunity. 8:383–390.
5. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T.
Sana, S.B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A.
O’Garra. 1997. IGIF does not drive Th1 development but
synergizes with IL-12 for interferon-g production and acti-
vates IRAK and NFkB. Immunity. 7:571–581.
6. Graham, M.B., D.K. Dalton, D. Giltinan, V.L. Braciale, T.A.
Stewart, and T.J. Braciale. 1993. Response to influenza infec-
tion in mice with a targeted disruption in the interferon g
gene. J. Exp. Med. 178:1725–1732.
7. Wang, Z.-E., S.L. Reiner, S. Zheng, D.K. Dalton, and R.M.
Locksley. 1994. CD41 effector cells default to the Th2 path-
way in interferon-g–deficient mice infected with Leishmania
major. J. Exp. Med. 179:1367–1371.
8. Bouley, D.M., S. Kanangat, W. Wire, and B.T. Rouse. 1995.
Characterization of herpes simplex virus type-1 infection and
herpetic stromal keratitis development in IFN-g knockout
mice. J. Immunol. 155:3964–3971.
9. Szabo, S.J., A.S. Dighe, U. Gubler, and K.M. Murphy. 1997.
Regulation of the interleukin (IL)-12R b2 subunit expres-
sion in developing T helper 1 (Th1) and Th2 cells. J. Exp.
Med. 185:817–824.
10. Ma, X., J.M. Chow, G. Gri, G. Carra, F. Gerosa, S.F. Wolf,
R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40
gene promoter is primed by interferon g in monocytic cells.
J. Exp. Med. 183:147–157.
11. Fowell, D.J., J. Magram, C.W. Turck, N. Killeen, and R.M.
Locksley. 1997. Impaired Th2 subset development in the ab-
sence of CD4. Immunity. 6:559–569.
12. Wu, C., J. Ferrante, M.K. Gately, and J. Magram. 1997.
Characterization of IL-12 receptor b1 chain (IL-12Rb1)-
deficient mice. J. Immunol. 159:1658–1665.
13. Arase, H., N. Arase, and T. Saito. 1996. Interferon g produc-
tion by natural killer (NK) cells and NK1.11 T cells upon
NKR-P1 cross-linking. J. Exp. Med. 183:2391–2396.
14. Pernis, A., S. Gupta, K.J. Gollob, E. Garfein, R.L. Coffman,
C. Schindler, and P. Rothman. 1995. Lack of interferon
gamma receptor beta chain and the prevention of interferon
1656 Th1 Development without Exogenous IFN-g
gamma signaling in Th1 cells. Science. 269:245–247.
15. Reiner, S.L., S. Zheng, Z.E. Wang, L. Stowring, and R.M.
Locksley. 1994. Leishmania promastigotes evade interleukin
12 (IL-12) induction by macrophages and stimulate a broad
range of cytokines from CD41 T cells during initiation of in-
fection. J. Exp. Med. 179:447–456.
16. Hsieh, C.-S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A.
O’Garra, and K.M. Murphy. 1993. Development of Th1
CD41 T cells through IL-12 produced by Listeria-induced
macrophages. Science. 260:547–549.
17. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Brad-
ley, and T.A. Stewart. 1993. Multiple defects of immune cell
function in mice with disrupted interferon-g genes. Science.
259:1739–1742.
18. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S.
Tonegawa, and V.E. Papaioannou. 1992. RAG-1-deficient
mice have no mature B and T lymphocytes. Cell. 68:869–877.
19. Openshaw, P., E.E. Murphy, N.A. Hosken, V. Maino, K.
Davis, K. Murphy, and A. O’Garra. 1995. Heterogeneity of
intracellular cytokine synthesis at the single-cell level in po-
larized T helper 1 and T helper 2 populations. J. Exp. Med.
182:1357–1367.
20. Ryan, J.C., E.C. Niemi, M.C. Nakamura, and W.E. Seaman.
1995. NKR-P1A is a target-specific receptor that activates
natural killer cell cytotoxicity. J. Exp. Med. 181:1911–1915.
21. Scharton, T.M., and P. Scott. 1993. Natural killer cells are a
source of interferon g that drives differentiation of CD41 T
cell subsets and induces early resistant to Leishmania major in
mice. J. Exp. Med. 178:567–577.
22. Laskay, T., M. Rollinghoff, and W. Solbach. 1993. Natural
killer cells participate in the early defense against Leishmania
major infection in mice. Eur. J. Immunol. 23:2237–2241.
23. Holaday, B.J., M.D. Sadick, Z.-E. Wang, S.L. Reiner, F.P.
Heinzel, T.G. Parslow, and R.M. Locksley. 1991. Reconsti-
tution of Leishmania immunity in severe combined immuno-
deficient mice using Th1- and Th2-like cell lines. J. Immunol.
147:1653–1658.
24. Reiner, S.L., and R.M. Locksley. 1995. The regulation of
immunity to Leishmania major. Annu. Rev. Immunol. 13:151–177.
25. Macatonia, S.E., C.-S. Hsieh, K.M. Murphy, and A.
O’Garra. 1993. Dendritic cells and macrophages are required
for Th1 development of CD41 T cells from ab TCR trans-
genic mice: IL-12 substitution for macrophages to stimulate
IFN-g production is IFN-g-dependent. Int. Immunol. 5:
1119–1128.
26. Wenner, C.A., M.L. Guler, S.E. Macatonia, A. O’Garra, and
K.M. Murphy. 1996. Roles of IFN-g and IFN-a in IL-12-
induced T helper cell-1 development. J. Immunol. 156:1442–
1447.
27. Bradley, L.M., D.K. Dalton, and M. Croft. 1996. A direct
role for IFN-g in regulation of Th1 cell development. J. Im-
munol. 157:1350–1358.
28. Nakamura, T., R.K. Lee, S.Y. Nam, E.R. Podack, K. Bot-
tomly, and R.A. Flavell. 1997. Roles of IL-4 and IFN-g in
stabilizing the T helper cell type 1 and 2 phenotype. J. Immu-
nol. 158:2648–2653.
29. Szabo, S.J., N.G. Jacobson, A.S. Dighe, U. Gubler, and K.M.
Murphy. 1995. Developmental commitment to the Th2 lin-
eage by extinction of IL-12 signaling. Immunity. 2:665–675.
30. Thierfelder, W.E., J.M. van Deursen, K. Yamamoto, R.A.
Tripp, S.R. Sarawar, R.T. Carson, M.Y. Sangster, D.A.A.
Vignali, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1996.
Requirement for stat4 in interleukin-12-mediated responses
of natural killer and T cells. Nature. 382:171–174.
31. Kaplan, M.H., Y.-L. Sun, T. Hoey, and M.J. Grusby. 1996.
Impaired IL-12 responses and enhanced development of Th2
cells in stat4-deficient mice. Nature. 382:174–177.
32. Flesch, I.E.A., J.H. Hess, S. Huang, M. Aguet, J. Rothe, H.
Bluethmann, and S.H.E. Kaufmann. 1995. Early interleukin
12 production by macrophages in response to mycobacterial
infection depends on interferon g and tumor necrosis factor
a. J. Exp. Med. 181:1615–1621.
33. Guler, M.L., J.D. Gorham, C.-S. Hsieh, A.J. Mackey, R.G.
Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic sus-
ceptibility to Leishmania: IL-12 responsiveness in Th1 cell
development. Science. 271:964–967.
34. Guler, M.L., N.G. Jacobson, U. Gubler, and K.M. Murphy.
1997. T cell genetic background determines maintenance of
IL-12 signaling. Effects on BALB/c and B10.D2 T helper cell
type 1 phenotype development. J. Immunol. 159:1767–1774.
35. Hsieh, C.-S., S.E. Macatonia, A. O’Garra, and K.M. Mur-
phy. 1995. T cell genetic background determines default T
helper phenotype development in vitro. J. Exp. Med. 181:
713–721.
36. Scharton-Kersten, T., L.C.C. Afonso, M. Wysocka, G.
Trinchieri, and P. Scott. 1995. IL-12 is required for natural
killer cell activation and subsequent T helper 1 development
in experimental leishmaniasis. J. Immunol. 154:5320–5330.
37. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995.
Requirement for natural killer cell–produced interferon
gamma in defense against murine cytomegalovirus infection
and enhancement of this defense pathway by interleukin 12
administration. J. Exp. Med. 182:1045–1056.
38. Diefenbach, A., H. Schindler, N. Donhauser, E. Lorenz, T.
Laskay, J. MacMicking, M. Rollinghoff, I. Gresser, and C.
Bogdan. 1998. Type 1 interferon (IFN a/b) and type 2 nitric
oxide synthase regulate the innate immune response to a pro-
tozoan parasite. Immunity. 8:77–87.
39. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan.
1994. Tissue expression of inducible nitric oxide synthase is
closely associated with resistance to Leishmania major. J. Exp.
Med. 180:783–793.
40. Schmitz, J., A. Thiel, R. Kuhn, K. Rajewsky, and W.
Muller. 1994. Induction of interleukin-4 (IL-4) expression in
T helper (Th) cells is not dependent on IL-4 from non-T
cells. J. Exp. Med. 179:1349–1353.
41. Launois, P., I. Maillard, S. Pingel, K.G. Swihart, I. Xenarios,
H. Acha-Orbea, H. Diggelmann, R.M. Locksley, H.R.
MacDonald, and J.A. Louis. 1997. IL-4 rapidly produced by
Vb4Va8 CD41 T cells instructs Th2 development and sus-
ceptibility to Leishmania major in BALB/c mice. Immunity. 6:
541–549.
42. Lange, C., T. Schuler, and T. Blankenstein. 1998. Interleukin
4 gene–defective mice reconstituted with wild-type bone
marrow fail to produce normal immunoglobulin E levels. J.
Exp. Med. 187:1487–1493.
